Lorraine Spector

Array ( [id] => 6472841 [patent_doc_number] => 20100041136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Connective Tissue Growth Factor-2' [patent_app_type] => utility [patent_app_number] => 12/579542 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10771 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041136.pdf [firstpage_image] =>[orig_patent_app_number] => 12579542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323020 [patent_doc_number] => 20100113755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'ISOLATED MODIFIED HUMAN CHORIONIC GONADOTROPIN PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/471983 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 117707 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113755.pdf [firstpage_image] =>[orig_patent_app_number] => 12471983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527595 [patent_doc_number] => 08044187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Human luteinizing hormone superagonists' [patent_app_type] => utility [patent_app_number] => 12/467081 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13816 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044187.pdf [firstpage_image] =>[orig_patent_app_number] => 12467081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4526373 [patent_doc_number] => 07923016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-12 [patent_title] => 'Engineered CXCL12 α locked dimer polypeptide' [patent_app_type] => utility [patent_app_number] => 12/380308 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19391 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/923/07923016.pdf [firstpage_image] =>[orig_patent_app_number] => 12380308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302861 [patent_doc_number] => 20090297513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'ANTIBODIES TO IL-6 AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/391717 [patent_app_country] => US [patent_app_date] => 2009-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 82521 [patent_no_of_claims] => 153 [patent_no_of_ind_claims] => 143 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297513.pdf [firstpage_image] =>[orig_patent_app_number] => 12391717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302784 [patent_doc_number] => 20090297436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'ANTIBODIES TO IL-6 AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/366567 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 77710 [patent_no_of_claims] => 137 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297436.pdf [firstpage_image] =>[orig_patent_app_number] => 12366567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5581351 [patent_doc_number] => 20090176697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Method to obtain the human Chorionic Gonadotropin (hCG)/cyclodextrin complex for oral administration, product obtained by this method and clinical and therapeutic use of the complex human Chorionic Gonadotropin (hCG)/cyclodextrin' [patent_app_type] => utility [patent_app_number] => 12/318073 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 2436 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176697.pdf [firstpage_image] =>[orig_patent_app_number] => 12318073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546591 [patent_doc_number] => 20090156468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Use of human chorionic gonadotropin oral or injectable for metabolic syndrome treatment' [patent_app_type] => utility [patent_app_number] => 12/314719 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1694 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156468.pdf [firstpage_image] =>[orig_patent_app_number] => 12314719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441774 [patent_doc_number] => 20090093413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'METHODS FOR THE MODULATION OF NEOVASCULARIZATION AND/OR THE GROWTH OF COLLATERAL ARTERIES AND/OR OTHER ARTERIES FROM PREEXISTING ARTERIOLAR CONNECTIONS' [patent_app_type] => utility [patent_app_number] => 12/332926 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7899 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093413.pdf [firstpage_image] =>[orig_patent_app_number] => 12332926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7728597 [patent_doc_number] => 08101188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections' [patent_app_type] => utility [patent_app_number] => 12/332906 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7915 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101188.pdf [firstpage_image] =>[orig_patent_app_number] => 12332906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379307 [patent_doc_number] => 20090191146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'METHODS FOR THE MODULATION OF NEOVASCULARIZATION AND/OR THE GROWTH OF COLLATERAL ARTERIES AND/OR OTHER ARTERIES FROM PREEXISTING ARTERIOLAR CONNECTIONS' [patent_app_type] => utility [patent_app_number] => 12/332937 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7879 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191146.pdf [firstpage_image] =>[orig_patent_app_number] => 12332937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545386 [patent_doc_number] => 20090155263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Compositions and methods for the treatment of immune related diseases' [patent_app_type] => utility [patent_app_number] => 12/315879 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 569 [patent_figures_cnt] => 569 [patent_no_of_words] => 53044 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12315879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480644 [patent_doc_number] => 20090203601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Method for the treatment of neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (G-CSF) variant' [patent_app_type] => utility [patent_app_number] => 12/313902 [patent_app_country] => US [patent_app_date] => 2008-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23644 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203601.pdf [firstpage_image] =>[orig_patent_app_number] => 12313902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4475770 [patent_doc_number] => 07906117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever' [patent_app_type] => utility [patent_app_number] => 12/323147 [patent_app_country] => US [patent_app_date] => 2008-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 90409 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906117.pdf [firstpage_image] =>[orig_patent_app_number] => 12323147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508034 [patent_doc_number] => 20090081241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Anti-TNF Antibodies, Compositions, Methods and Uses' [patent_app_type] => utility [patent_app_number] => 12/271120 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 41877 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081241.pdf [firstpage_image] =>[orig_patent_app_number] => 12271120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315526 [patent_doc_number] => 20090280124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Methods for the Diagnosis and Treatment of Preeclampsia' [patent_app_type] => utility [patent_app_number] => 12/268169 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 197317 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280124.pdf [firstpage_image] =>[orig_patent_app_number] => 12268169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5409612 [patent_doc_number] => 20090123510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Medical implants containing adenosine receptor agonists and methods for inhibiting medical implant loosening' [patent_app_type] => utility [patent_app_number] => 12/291510 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15681 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123510.pdf [firstpage_image] =>[orig_patent_app_number] => 12291510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8188342 [patent_doc_number] => 08182814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Methods of treating inflammatory airway conditions by inhibition of IL-11 activity' [patent_app_type] => utility [patent_app_number] => 12/256883 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14704 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/182/08182814.pdf [firstpage_image] =>[orig_patent_app_number] => 12256883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441359 [patent_doc_number] => 20090092998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'MARKER FOR ARRHYTHMIA RISK' [patent_app_type] => utility [patent_app_number] => 12/207985 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5248 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092998.pdf [firstpage_image] =>[orig_patent_app_number] => 12207985 [rel_patent_id] =>[rel_patent_doc_number] =>)